Der Juni ist der Monat der Krebsüberlebenden (National Cancer Survivor Month), in dem wir die von Krebs betroffenen Menschen ehren und ihrer gedenken, um das Bewusstsein für das Überleben von Krebs zu schärfen und diejenigen zu unterstützen, die derzeit mit der Krankheit kämpfen.
Im Rahmen unseres Engagements für diese wichtige Sache haben wir eine Reihe von Veröffentlichungen zusammengestellt, die wertvolle Erkenntnisse über die Behandlung von Oncothermie bieten, die sich positiv auf die Überlebenszeit und die Lebensqualität auswirken.
Minnaar CA, Maposa I, Kotzen JA, Baeyens A. (2022)
Effects of modulated electro-hyperthermia (mEHT) on two and three year survival of locally advanced cervical cancer patients,
Cancers, 14, 656,
Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,
Journal of Advanced Research, 24:175-182,
Fiorentini G, Sarti D, Casadei V, et.al. (2020)
Modulated electro-hyperthermia for the treatment of relapsed brain gliomas, in book Challenges and solutions of oncological hyperthermia, ed. Szasz A., Ch. 6, pp.110-125, Cambridge Scholars,
Fiorentini G, Sarti D, Casadei V, et al. (2019)
Modulated electro-hyperthermia as palliative treatment for pancreas cancer: A retrospective observational study on 106 patients,
Integrative Cancer Therapies, Vol. 18:1-8,
Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,
Journal of Advanced Research, 24:175-182,
Iyikesici MS. (2020)
Long-term survival outcomes of metabolically supported chemotherapy with Gemcitabine-based or FOLFIRINOX regimen combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in metastatic pancreatic cancer,
Complement Med Res, 27(1):31-39,
Iyikesici MS. (2020)
Survival outcomes of metabolically supported chemotherapy combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer,
Nigerian Journal of Clinical Practice, 23:734-40,
Parmar G. (2018)
Naturopathic Anti-Tumoral Treatment & 8 Year Survival Benefit Statistics: A Single-Centre Experience;
Oncothermia Journal 24:405-425,
Ou J, Zhu X, Lu Y, et.al. (2017)
The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer,
European J Pharmaceutical Sciences, 109:412-418,
Pang CLK, Zhang X, Wang Z, et.al. (2017)
Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial,
Molecular and Clinical Oncology, 6:723-732,
Schirrmacher V, Stücker W, Lulei M, et.al. (2015)
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report;
Immunotherapy 7: 855–860,
Reimnitz U. (2010)
Cholangiocellular carcinomas: survival without symptoms with hyperthermia – A case study.
Oncothermia Journal 1:20-22,
